Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Eloria vs EmbraceRX

Eloria
Graded #214

Higher grade

vs+6.999999999999993
EmbraceRX
Graded #363

Lower grade

The verdict

Eloria takes it — 65.6/100 to 58.6/100.

Eloria grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eloria is a clinician-led GLP-1 weight-loss telehealth platform operated by Arora Health & Aesthetics.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEloria +4
49
45
Dose & formulationEloria +20
76
56
Clinical oversightEloria +3
79
76
Labs & monitoringEven
52
52
FulfillmentEloria +8
81
73
Contract termsEloria +6
61
55
Eloria · left barEmbraceRX · right bar

The numbers

MetricEloriaEmbraceRX
WeighScore65.6/10058.6/100
GradeCC
Scorecard rank#214#363
Semaglutide$179/mo (starting dose, plus a separate fee, compounded)Not disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesYes
Eloria

Graded #214 · C

Strengths

  • Compounded GLP-1 injections from $179/mo and oral dissolving tablets from $249/mo, with no membership or hidden fees
  • Also offers brand Wegovy (pill or injection) on a $99/mo membership plus medication cost
  • Board-certified providers (via Arora Health & Aesthetics) and US-licensed pharmacies
  • HSA/FSA accepted, free shipping on every order, and 24/7 support
  • Full published compliance suite (Terms, Privacy, Refund, Shipping, Physician Code of Conduct, Consent to Telehealth)

Where it loses points

  • Compounded medications are not FDA-approved - not brand Ozempic, Zepbound, or Mounjaro
  • State availability varies and is not published - only where providers are licensed and pharmacies can dispense
  • The compounding pharmacy partner is not named (US-licensed pharmacies only)
  • No LegitScript certification displayed
  • Brand Wegovy uses a separate $99/mo membership-plus-medication-cost model
EmbraceRX

Graded #363 · C

Strengths

  • Broad compounded GLP-1 menu — semaglutide (+B12), tirzepatide, oral semaglutide/tirzepatide capsules, plus Lipo-B
  • Large peptide/longevity catalog (BPC-157, GHK-Cu, NAD+, MOTS-C) across injectable, oral, topical, and nasal formats
  • Clinician-guided, compounded at FDA-registered pharmacies; partners with a licensed physician network (Samaritan MD)
  • Full legal suite published (Terms, Privacy, HIPAA Notice, CCPA, Returns & Refunds)

Where it loses points

  • Pricing not shown upfront — revealed only at checkout after a dose selection
  • Offers investigational/research compounds (e.g., retatrutide, AOD-9604) that are not FDA-approved
  • Compounding pharmacy partner not named ('FDA-registered pharmacies')
  • Not LegitScript-certified (no certification displayed)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard